The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II randomized trial of afatinib with or without cetuximab as first-line treatment for EGFR mutated non-small cell lung cancer (NSCLC) patients (IFCT-1503 ACE-Lung).
 
Alexis B. Cortot
Honoraria - Bristol-Myers Squibb; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; Pfizer; Roche
Research Funding - Merck Serono (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Anne Madroszyk
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Pfizer; Roche
 
Etienne Giroux Leprieur
No Relationships to Disclose
 
Olivier Molinier
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Elisabeth A. Quoix
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche; Takeda
 
Henri Berard
Research Funding - Roche (Inst)
 
Josianne Otto
No Relationships to Disclose
 
Isabelle Rault
No Relationships to Disclose
 
Judith Raimbourg
Travel, Accommodations, Expenses - Amgen; Roche
 
Jose Hureaux
No Relationships to Disclose
 
Lionel Moreau
No Relationships to Disclose
 
Didier Debieuvre
No Relationships to Disclose
 
Hugues Morel
No Relationships to Disclose
 
Marc G. Denis
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche; Takeda
Research Funding - Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Takeda
 
Elodie Amour
No Relationships to Disclose
 
Franck Morin
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Denis Moro-Sibilot
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly/ImClone; MSD Oncology; Novartis; Pfizer/EMD Serono; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche/Genentech; Takeda
 
Jacques Cadranel
No Relationships to Disclose